Amino acid replacement: Q180term.
Nucleotide substitution: C?T.
C16106010T
C?T
Q180term | Rho1-PA; Q180term | Rho1-PB; Q180term | Rho1-PC; Q180term | Rho1-PD; Q180term | Rho1-PF; Q180term | Rho1-PG
Q180term
E(zip)31-631-6, Rho1J3.8/Rho1[+] has visible | dominant phenotype
Rho1J3.8/Rho1[+], RhoGEF211-3 has visible | dominant phenotype
Rho1J3.8/Rho1[+], RhoGEF211-3 has partially lethal phenotype
E(zip)12-512-5, Rho1J3.8/Rho1[+] has visible | dominant phenotype
E(zip)12-512-5, Rho1J3.8/Rho1[+] has partially lethal phenotype
E(zip)18-518-5, Rho1J3.8/Rho1[+] has visible | dominant phenotype
Df(3R)sbd105/+, Rho1J3.8 has visible | dominant phenotype
E(zip)12-5[+]/E(zip)12-512-5, Rho1J3.8 has visible phenotype
E(zip)18-5[+]/E(zip)18-518-5, Rho1J3.8 has visible phenotype
E(zip)31-631-6/E(zip)31-6[+], Rho1J3.8 has visible phenotype
Rho1J3.8, RhoGEF204291/RhoGEF2[+] has visible phenotype
Rho1J3.8, RhoGEF21.1/RhoGEF2[+] has visible phenotype
Rho1J3.8, RhoGEF211-3/RhoGEF2[+] has visible phenotype
Rho1J3.8, RhoGEF24.1/RhoGEF2[+] has visible phenotype
Rho1J3.8/Rho1[+], RhoGEF204291 has visible | dominant phenotype
Rho1J3.8/Rho1[+], RhoGEF21.1 has visible | dominant phenotype
Rho1J3.8/Rho1[+], RhoGEF24.1 has visible | dominant phenotype
E(br)121Ebr121, Rho1J3.8/Rho1[+] has visible | dominant phenotype
E(br)121Ebr121/E(br)121[+], Rho1J3.8 has visible phenotype
E(br)420[+]/E(br)420Ebr420, Rho1J3.8 has visible phenotype
E(br)444[+]/E(br)444Ebr444, Rho1J3.8 has visible phenotype
E(br)65Ebr65/E(br)65[+], Rho1J3.8 has visible phenotype
E(br)420Ebr420, Rho1J3.8/Rho1[+] has visible | dominant phenotype
E(br)444Ebr444, Rho1J3.8/Rho1[+] has visible | dominant phenotype
E(br)65Ebr65, Rho1J3.8/Rho1[+] has visible | dominant phenotype
Rho1J3.8, zipEbr has partially lethal - majority die | dominant phenotype
Rho1J3.8, zip[+]/zipEbr has partially lethal - majority die | dominant phenotype
Rho1J3.8/Rho1[+], zipEbr has partially lethal - majority die | dominant phenotype
Rho1J3.8, zip[+]/zipEbr has partially lethal - majority live phenotype
E(zip)31-631-6, Rho1J3.8/Rho1[+] has wing phenotype
Rho1J3.8/Rho1[+], RhoGEF211-3 has wing phenotype
Rho1J3.8/Rho1[+], RhoGEF211-3 has leg phenotype
E(zip)12-512-5, Rho1J3.8/Rho1[+] has wing phenotype
E(zip)12-512-5, Rho1J3.8/Rho1[+] has leg phenotype
E(zip)31-631-6, Rho1J3.8/Rho1[+] has leg phenotype
E(zip)18-518-5, Rho1J3.8/Rho1[+] has wing phenotype
E(zip)18-518-5, Rho1J3.8/Rho1[+] has leg phenotype
Df(3R)sbd105/+, Rho1J3.8 has leg phenotype
E(zip)12-512-5, Rho1J3.8 has wing phenotype
E(zip)12-512-5, Rho1J3.8 has leg phenotype
Rho1J3.8, RhoGEF211-3 has wing phenotype
Rho1J3.8, RhoGEF211-3 has leg phenotype
E(zip)18-518-5, Rho1J3.8 has wing phenotype
E(zip)18-518-5, Rho1J3.8 has leg phenotype
E(zip)31-631-6, Rho1J3.8 has wing phenotype
E(zip)31-631-6, Rho1J3.8 has leg phenotype
Rho1J3.8, RhoGEF204291 has leg phenotype
Rho1J3.8, RhoGEF21.1 has leg phenotype
Rho1J3.8, RhoGEF24.1 has leg phenotype
Rho1J3.8/Rho1[+], RhoGEF204291 has leg phenotype
Rho1J3.8/Rho1[+], RhoGEF21.1 has leg phenotype
Rho1J3.8/Rho1[+], RhoGEF24.1 has leg phenotype
E(br)121Ebr121, Rho1J3.8/Rho1[+] has leg phenotype
E(br)121Ebr121, Rho1J3.8 has leg phenotype
E(br)420Ebr420, Rho1J3.8 has leg phenotype
E(br)444Ebr444, Rho1J3.8 has leg phenotype
E(br)65Ebr65, Rho1J3.8 has leg phenotype
E(br)420Ebr420, Rho1J3.8/Rho1[+] has leg phenotype
E(br)444Ebr444, Rho1J3.8/Rho1[+] has leg phenotype
E(br)65Ebr65, Rho1J3.8/Rho1[+] has leg phenotype
Rho1J3.8 shows a strong interaction (at least 50% of double heterozygotes have at least one malformed leg) with the following mutations: RhoGEF211-3, E(zip)12-512-5, E(zip)18-518-5, E(zip)31-631-6, zip33-1, Sb63b and Sb70. Rho1J3.8 shows a moderate interaction (25-49% of double heterozygotes have at least one malformed leg) with the following mutations: Df(3R)sbd105. Rho1J3.8 shows a weak interaction (5-24% of double heterozygotes have at least one malformed leg) with the following mutations: Sb1, SbSpi. Rho1J3.8 shows no interaction with sqhunspecified (assayed in terms of a malformed leg phenotype). Rho1J3.8 shows a strong interaction (at least 50% of double heterozygotes have at least one malformed wing) with the following mutations: Sb63b, Sb70, RhoGEF211-3 and E(zip)12-512-5. Rho1J3.8 shows a moderate interaction (25-49% of double heterozygotes have at least one malformed wing) with the following mutations: E(zip)18-518-5 and E(zip)31-631-6. Sbsbd-201/Sbsbd-1 shows a strong interaction (at least 50% of double mutants have at least one malformed leg) with the following mutations: Rho1J3.8/+.
Dominantly enhances the frequency of br1 mutant animals with malformed legs. The fraction of flies showing a malformed leg phenotype in at least one leg, for Rho1J3.8 in double heterozygous combination with one of the following alleles is - SbEbr20 : 16%, SbEbr48 : 15%, SbEbr228 : 3%, SbEbr448 : 15%, SbEbr536 : 19%, SbEbr623 : 21%, bsEbr292 : 7%, E(br)24Ebr24 : 11%, E(br)65Ebr65 : 28%, E(br)155Ebr155 : 57%, E(br)165Ebr165 : 15%, E(br)333Ebr333 : 1%, E(br)72Ebr72 : 16%, E(br)121Ebr121 : 37%, E(br)160Ebr160 : 7%, E(br)187Ebr187 : 1%, E(br)420Ebr420 : 21% and E(br)444Ebr444 : 29%.